Brazil is reforming the system for registering medical device "product groupings". Draft regulations issued for public consultation seek to address the "need to establish new criteria on how medical devices are organised and grouped" for the purpose of registration with healthcare surveillance agency Anvisa - or their exemption from this; they also, crucially, redefine the concepts of product families, kits/sets, systems and stand-alone products.
Anvisa's proposals, published in the Diario Oficial da Uniao (DOU) of March 6 (downloadable also from the Anvisa website, www.anvisa.gob.br),...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?